Accuprec Research Labs Pvt. Ltd. is delighted to participate in CPHI Korea 2026, one of Asia’s leading pharmaceutical exhibitions, bringing together pharmaceutical manufacturers, biotechnology companies, medical device organizations, research institutes, regulatory experts and healthcare innovators from across the globe.
We invite you to visit us at Booth PA04 to explore our comprehensive range of pharmaceutical, medical device and specialty analytical testing services. With globally recognized regulatory compliance, advanced laboratory infrastructure and decades of scientific expertise, Accuprec serves as a trusted Contract Research Organization (CRO) for companies seeking reliable testing, validation and regulatory support.
Event Details
Event
CPHI Korea 2026
Date
25th – 27th August 2026
Venue
COEX Convention & Exhibition Center, Seoul, South Korea
Booth No.
PA04
Meet our scientific experts to discuss your upcoming projects, regulatory challenges, product development requirements and customized analytical solutions.
Meet Our Experts
Our experienced leadership team will be available throughout the exhibition to discuss your testing requirements, research projects and regulatory challenges.
Dr. Rina Gokani
Director & CSO
Dr. Manish Rachchh
Director & CEO
Mr. Mayur Kandoriya
Director & CMOMs. Shreya Chandarana
Executive (Business Development)Whether you are developing pharmaceuticals, biologics, complex formulations, nanotechnology products, or medical devices, our experts are ready to help you identify the right analytical and regulatory solutions for your project.
Why Visit Accuprec at CPHI Korea?
At Accuprec, we combine scientific excellence with regulatory expertise to help pharmaceutical and medical device companies accelerate product development while ensuring global compliance.
During the exhibition, you can:
- Discuss your analytical and testing requirements directly with our experts.
- Explore customized solutions for pharmaceutical and medical device development.
- Learn about our latest laboratory capabilities.
- Understand international regulatory expectations.
- Discover faster, reliable and compliant testing solutions.
- Build long-term partnerships for research, testing and validation services.
Our Core Testing & Research Services
Nitrosamine & NDSRI Testing
Nitrosamines and Nitrosamine Drug Substance Related Impurities (NDSRIs) have become a major regulatory concern worldwide. Accuprec offers highly sensitive analytical testing using advanced instrumentation to detect trace-level impurities, helping manufacturers comply with USFDA, EMA and global regulatory requirements while ensuring patient safety.
Extractable & Leachable Testing (E&L) & Toxicological Risk Assessment (TRA)
Packaging systems, containers, closures and medical devices may release chemical compounds that can affect product safety and efficacy.
Our comprehensive Extractable & Leachable studies identify these compounds, while Toxicological Risk Assessments evaluate their potential health impact, supporting complete regulatory submissions and risk management.
Toxicological & Preclinical Testing
Accuprec provides comprehensive toxicological and preclinical evaluation services to assess product safety before clinical use.
Our experienced scientific team conducts studies in accordance with international regulatory guidelines, generating high-quality data that supports regulatory submissions and product development.
Iron Carbohydrate Complex Characterization
We offer advanced analytical characterization of Iron Carbohydrate Complexes using sophisticated instrumentation and scientifically validated methods.
Our services assist manufacturers in demonstrating product quality, structural similarity, physicochemical properties and regulatory compliance.
Carrier Vehicle-Based Particle Characterization (Liposomes & Nanosomes)
Nanotechnology-based drug delivery systems require precise characterization for quality, stability and performance.
Accuprec specializes in comprehensive particle characterization for Liposomes, Nanosomes and other carrier-based drug delivery systems, including particle size analysis, morphology evaluation, zeta potential and related analytical assessments.
IVRT & IVPT Studies
Our laboratory performs In Vitro Release Testing (IVRT) and In Vitro Permeation Testing (IVPT) to support topical and transdermal drug product development.
These studies help manufacturers evaluate product performance, establish bioequivalence, optimize formulations and fulfill global regulatory requirements.
Method Development & Validation
Accuprec develops robust, reliable and regulatory-compliant analytical methods for pharmaceutical products, raw materials, impurities and medical devices.
Our validation studies are performed according to internationally accepted guidelines to ensure accuracy, precision, specificity, robustness and reproducibility.
Pre-filled Syringe Testing (ISO 11040)
Pre-filled syringe systems require rigorous evaluation to ensure product integrity and patient safety.
Our comprehensive ISO 11040 testing services include dimensional analysis, functional performance testing, container closure integrity evaluation and compatibility assessments to support regulatory compliance.
Why Choose Accuprec Research Labs?
- Globally trusted Contract Research Organization (CRO)
- Advanced analytical and testing laboratories
- Experienced multidisciplinary scientific team
- Comprehensive pharmaceutical & medical device testing solutions
- International regulatory expertise
- High-quality, accurate and reliable test results
- Customized project support
- Timely project execution
- Commitment to scientific excellence and regulatory compliance
